Skip to content

Clinical trials

Cardiomyopathy, Hypertrophic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathy, Hypertrophic Clear all

352 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20022
20032
20051
20065
20075
20081
20095
20107
20117
20128
20139
201415
201511
201612
201714
201818
201921
202023
202115
202219
202332
202433
202532
202631

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed135
Unknown status68
Recruiting66
Active, not recruiting29
Not yet recruiting21
Terminated17
Enrolling by invitation10
Withdrawn6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb25
National Heart, Lung, and Blood Institute (NHLBI)24
Xijing Hospital11
China National Center for Cardiovascular Diseases9
Chinese Academy of Medical Sciences, Fuwai Hospital6
Mayo Clinic6
Meshalkin Research Institute of Pathology of Circulation6
Shandong Suncadia Medicine Co., Ltd.6
Cytokinetics5
Imperial College London5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathy, Hypertrophic352
Cardiomyopathy, Dilated38
Cardiomyopathies29
Heart Failure20
Arrhythmogenic Right Ventricular Dysplasia15
Cardiomyopathy, Restrictive13
Hypertrophy, Left Ventricular13
Cardiovascular Diseases12
Death, Sudden, Cardiac11
Heart Diseases11

Trials

Showing 51 to 75 of 352. Each trial links to its page on Pharma Observatory.

252 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.